Opioid and non-opioid analgesics

Best Practice and Research: Clinical Anaesthesiology

Volumn 17, Issue 1, 2003, Pages 91-110

  Schug, Stephan A ^a   Robert Garrett, William ^b   Gillespie, Gail ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Adverse effect; Aspirin; Morphine; NSAID; Opioid; Paracetamol; Toxicity

Indexed keywords

ALFENTANIL; BREMAZOCINE; BUPRENORPHINE; BUTORPHANOL; DEXTROPROPOXYPHENE; DEZOCINE; DIAMORPHINE; FENTANYL; MEPTAZINOL; METHADONE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 ACETATE; MORPHINE 6 GLUCURONIDE; NALBUPHINE; NALORPHINE; NALOXONE; NALTREXONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORMORPHINE; NORPETHIDINE; NORPROPOXYPHENE; OPIATE; OPIATE RECEPTOR; PARACETAMOL; PENTAZOCINE; PETHIDINE; REMIFENTANIL; SUFENTANIL; UNINDEXED DRUG; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT;

ABDOMINAL PAIN; AGRANULOCYTOSIS; AMENORRHEA; ANALGESIC NEPHROPATHY; ANOREXIA; ANUS DISEASE; APNEA; ASTHMA; BILIARY TRACT DISEASE; BLEEDING; BLEEDING TENDENCY; BLOOD TOXICITY; BLOOD VESSEL OCCLUSION; BRADYCARDIA; BRAIN DISEASE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRONCHOSPASM; CANCER PAIN; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COLITIS; COLLAGENOUS COLITIS; COMA; COMPLEX PARTIAL SEIZURE; CONSTIPATION; CORONARY ARTERY SPASM; DELIRIUM; DEMETHYLATION; DIAPHORESIS; DIGESTIVE SYSTEM ULCER; DISEASE EXACERBATION; DISSEMINATED INTRAVASCULAR CLOTTING; DIZZINESS; DROWSINESS; DRUG ACCUMULATION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHORIA; DYSURIA; EDEMA; EMOTIONAL DISORDER; ENTERITIS; ENTEROPATHY; ENZYME INHIBITION; EOSINOPHILIC ENTERITIS; ESOPHAGITIS; ESOPHAGUS STRICTURE; EUPHORIA; FERTILIZATION; FRACTURE NONUNION; GANGRENE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; GONADOTROPIN BLOOD LEVEL; HALLUCINATION; HAND INJURY; HEADACHE; HEART ARRHYTHMIA; HEART INFARCTION; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPERALGESIA; HYPERTENSION; HYPOTENSION; IMMUNE DEFICIENCY; IMPLANTATION; INFERTILITY; INTESTINE PERFORATION; IRON DEFICIENCY ANEMIA; ISCHEMIA; ISCHEMIC COLITIS; JAUNDICE; KIDNEY FAILURE; LEUKEMOID REACTION; LIBIDO DISORDER; LIVER TOXICITY; LUNG EDEMA; MALABSORPTION; MALAISE; MIOSIS; MUSCLE RIGIDITY; MYOCLONUS; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OPIATE ADDICTION; OVARY INSUFFICIENCY; PAIN; PALLOR; PANCYTOPENIA; PLASMACYTOSIS; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; PRURITUS; PSEUDOMEMBRANOUS COLITIS; RECTUM DISEASE; RECTUM ULCER; RESPIRATION DEPRESSION; RESPIRATORY ACIDOSIS; REVIEW; REYE SYNDROME; SEPSIS; SEROTONIN SYNDROME; SICKLE CELL ANEMIA; SKIN DEFECT; SODIUM RETENTION; SOMNOLENCE; STOMACH DISEASE; STOMACH EMPTYING; STOMACH OBSTRUCTION; STOMACH PERFORATION; STOMACH ULCER; SWEAT GLAND DISEASE; TACHYCARDIA; TEMPORAL LOBE EPILEPSY; TESTOSTERONE BLOOD LEVEL; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; THROMBOCYTOSIS; THROMBOSIS; URINE RETENTION; UROGENITAL TRACT DISEASE; VISUAL IMPAIRMENT; WITHDRAWAL SYNDROME; ANIMAL; BREATHING; DRUG EFFECT; HEMODYNAMICS; KIDNEY; LIVER;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; LIVER; RESPIRATION;

EID: 0038387341     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1053/bean.2003.0267     Document Type: Article

References (97)

1. Penson RT Joel SP Clark S et al. Limited phase I study of morphine-3-glucuronide Journal of Pharmaceutical Science 90 2001 1810-1816
2. Christensen CB Jorgensen LN Morphine-6-glucuronide has high affinity for the opioid receptor Pharmacology and Toxicology 60 1987 75-76
3. Knight B Thomson N Perry G Seizures due to norpethidine toxicity Australia and New Zealand Journal of Medicine 30 2000 513
4. Nickander RC Emmerson JL Hynes MD et al. Pharmacologic and toxic effects in animals of dextropropoxyphene and its major metabolite norpropoxyphene: a review Human Toxicology 3 1984 13S-36S supplement
5. Mazoit JX Sandouk P Zetlaoui P et al. Pharmacokinetics of unchanged morphine in normal and cirrhotic subjects Anesthesia & Analgesia 66 1987 293-298
6. Davies G Kingswood C Street M Pharmacokinetics of opioids in renal dysfunction Clinical Pharmacokinetics 31 1996 410-422
7. Power BM Forbes AM van Heerden PV et al. Pharmacokinetics of drugs used in critically ill adults Clinical Pharmacokinetics 34 1998 25-56
8. Pauli-Magnus C Hofmann U Mikus G et al. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis Nephrology Dialysis and Transplantation 14 1999 903-909
9. Chaney MA Side effects of intrathecal and epidural opioids Canadian Journal of Anaesthesia 42 1995 891-903
10. White JM Irvine RJ Mechanisms of fatal opioid overdose Addiction 94 1999 961-972
11. Schug SA Zech D Grond S Adverse effects of systemic opioid analgesics Drug Safety 7 1992 200-213
12. Santiago TV Johnson J Riley DJ et al. Effects of morphine on ventilatory response to exercise Journal of Applied Physiology 47 1979 112-118
13. Bailey PL Pace NL Ashburn MA et al. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl Anesthesiology 73 1990 826-830
14. Garrick TM Sheedy D Abernethy J et al. Heroin-related deaths in Sydney, Australia. How common are they? American Journal of Addiction 9 2000 172-178
15. Hamilton RJ Perrone J Hoffman R et al. A descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine Journal of Toxicology & Clinical Toxicology 38 2000 597-608
16. Vickers MD O'Flaherty D Szekely SM et al. Tramadol: pain relief by an opioid without depression of respiration Anaesthesia 47 1992 291-296
17. Barnung SK Treschow M Borgbjerg FM Respiratory depression following oral tramadol in a patient with impaired renal function Pain 71 1997 111-112
18. Bowdle TA Adverse effects of opioid agonists and agonist-antagonists in anaesthesia Drug Safety 19 1998 173-189
19. Bowdle TA Myoclonus following sufentanil without EEG seizure activity Anesthesiology 67 1987 593-595
20. Cascino GD So EL Sharbrough FW et al. Alfentanil-induced epileptiform activity in patients with partial epilepsy Journal of Clinical Neurophysiology 10 1993 520-525
21. Tempelhoff R Modica PA Bernardo KL et al. Fentanyl-induced electrocorticographic seizures in patients with complex partial epilepsy Journal of Neurosurgery 77 1992 201-208
22. Daeninck PJ Bruera E Opioid use in cancer pain. Is a more liberal approach enhancing toxicity? Acta Anaesthesiologica Scandinavica 43 1999 924-938
23. McHugh GJ Norpethidine accumulation and generalized seizure during pethidine patient-controlled analgesia Anaesthesia in Intensive Care 27 1999 289-291
24. Gasse C Derby L Vasilakis-Scaramozza C et al. Incidence of first-time idiopathic seizures in users of tramadol Pharmacotherapy 20 2000 629-634
25. Gardner JS Blough D Drinkard CR et al. Tramadol and seizures: a surveillance study in a managed care population Pharmacotherapy 20 2000 1423-1431
26. Schmelz M Itch-mediators and mechanisms Journal of Dermatological Science 28 2002 91-96
27. Mardirosoff C Dumont L Boulvain M et al. Fetal bradycardia due to intrathecal opioids for labour analgesia: a systematic review International Journal of Obstetrics and Gynaecology 109 2002 274-281
28. Kjellberg F Tramer MR Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials European Journal of Anaesthesiology 18 2001 346-357
29. Pugsley MK The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system Pharmacology and Therapeutics 93 2002 51-75
30. Fahmy NR Sunder N Soter NA Role of histamine in the hemodynamic and plasma catecholamine responses to morphine Clinical Pharmacology and Therapeutics 33 1983 615-620
31. Bruera E Miller MJ Non-cardiogenic pulmonary edema after narcotic treatment for cancer pain Pain 39 1989 297-300
32. Karch SB Stephens BG Toxicology and pathology of deaths related to methadone: retrospective review Western Journal of Medicine 172 2000 11-14
33. Todd JG Nimmo WS Effect of premedication on drug absorption and gastric emptying British Journal of Anaesthesia 55 1983 1189-1193
34. Latta KS Ginsberg B Barkin RL Meperidine: a critical review American Journal of Therapeutics 9 2002 53-68
35. Finch PM Roberts LJ Price L et al. Hypogonadism in patients treated with intrathecal morphine Clinical Journal of Pain 16 2000 251-254
36. Verebey KG Mule SJ Naltrexone (Trexan): a review of hepatotoxicity issues NIDA Research Monographs 67 1986 73-81
37. Rosenberg WM Ryley NG Trowell JM et al. Dextropropoxyphene induced hepatotoxicity: a report of nine cases Journal of Hepatology 19 1993 470-474
38. Gomez-Lechon MJ Ponsoda X Jover R et al. Hepatotoxicity of the opioids morphine, heroin, meperidine, and methadone to cultured human hepatocytes Molecular Toxicology 1 1987 453-463
39. Gerber N Apseloff G Death from a morphine infusion during a sickle cell crisis Journal of Pediatrics 123 1993 322-325
40. Pryle BJ Grech H Stoddart PA et al. Toxicity of norpethidine in sickle cell crisis British Medical Journal 304 1992 1478-1479
41. Govitrapong P Suttitum T Kotchabhakdi N et al. Alterations of immune functions in heroin addicts and heroin withdrawal subjects Journal of Pharmacology and Experimental Therapeutics 286 1998 883-889
42. Palm S Lehzen S Mignat C et al. Does prolonged oral treatment with sustained-release morphine tablets influence immune function? Anesthesia & Analgesia 86 1998 166-172
43. Laxenaire MC [Substances responsible for peranesthetic anaphylactic shock. A third French multicenter study (1992-94)] Annales Francaises d'Anesthisie et de Reanimation 15 1996 1211-1218
44. Nasser SM Ewan PW Opiate-sensitivity: clinical characteristics and the role of skin prick testing Clinical and Experimental Allergy 31 2001 1014-1020
45. Clissold SP Paracetamol and phenacetin Drugs 32 1986 46-59 Supplement 4
46. Prescott LF Paracetamol, alcohol and the liver British Journal of Clinical Pharmacology 49 2000 291-301
47. Kuffner EK Dart RC Bogdan GM et al. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial Archives of Internal Medicine 161 2001 2247-2252
48. Lee WM Drug-induced hepatotoxicity New England Journal of Medicine 333 1995 1118-1127
49. Wallace CI Dargan PI Jones AL Paracetamol overdose: an evidence based flowchart to guide management Emergency Medicine Journal 19 2002 202-205
50. Kozer E Koren G Management of paracetamol overdose: current controversies Drug Safety 24 2001 503-512
51. Nanra RS Analgesic nephropathy Medical Journal of Australia 1 1976 745-748
52. Avellaneda C Gomez A Martos F et al. The effect of a single intravenous dose of metamizol 2 g, ketorolac 30 mg and propacetamol 1 g on haemodynamic parameters and postoperative pain after heart surgery European Journal of Anaesthesiology 17 2000 85-90
53. Shaheen SO Sterne JA Songhurst CE et al. Frequent paracetamol use and asthma in adults Thorax 55 2000 266-270
54. Ayonrinde OT Saker BM Anaphylactoid reactions to paracetamol Postgraduate Medical Journal 76 2000 501-502
55. Barbaud A Reichert-Penetrat S Trechot P et al. Occupational contact dermatitis to propacetamol. Allergological and chemical investigations in two new cases Dermatology 195 1997 329-331
56. Niemi TT Backman JT Syrjala MT et al. Platelet dysfunction after intravenous ketorolac or propacetamol Acta Anaesthesiologica Scandinavica 44 2000 69-74
57. Oliver M Coton T Badens C et al. Homozygous G6PD deficiency and propacetamol induced hemolysis Haematologica 86 2001 987-988
58. Blower AL Brooks A Fenn GC et al. Emergency admissions for upper gastrointestinal disease and their relation to NSAID use Alimentary Pharmacology and Therapeutics 11 1997 283-291
59. Buttgereit F Burmester GR Simon LS Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors American Journal of Medicine 110 2001 13S-19S supplement 3A
60. Johnson AG Day RO The problems and pitfalls of NSAID therapy in the elderly (Part I) Drugs and Aging 1 1991 130-143
61. Wilder-Smith CH The clinical challenge of reducing toxicity Drug Safety 18 1998 457-472
62. Silverstein FE Faich G Goldstein JL et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study JAMA 284 2000 1247-1255
63. Hawkey CJ Tulassay Z Szczepanski L et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention Lancet 352 1998 1016-1021
64. Lanas A Hirschowitz BI Significant role of aspirin use in patients esophagitis Journal of Clinical Gastroenterology 13 1991 622-627
65. Kim SL Hunter JG Wo JM et al. NSAIDs, aspirin, and esophageal strictures: are over-the-counter medications harmful to the esophagus? Journal of Clinical Gastroenterology 29 1999 32-34
66. Davies NM Saleh JY Skjodt NM Detection and prevention of NSAID-induced enteropathy Journal of Pharmacy and Pharmaceutical Sciences 3 2000 137-155
67. Garcia B Ramaholimihaso F Diebold MD et al. Ischaemic colitis in a patient taking meloxicam Lancet 357 2001 690
68. Appu S Thompson G Gangrenous ischaemic colitis following non-steroidal anti-inflammatory drug overdose Australia and New Zealand Journal of Surgery 71 2001 694-695
69. Mahadevan U Loftus EV Jr Tremaine WJ et al. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease American Journal of Gastroenterology 97 2002 910-914
70. Whelton A Hamilton CW Nonsteroidal anti-inflammatory drugs: effects on kidney function Journal of Clinical Pharmacology 31 1991 588-598
71. Harris RC Jr Cyclooxygenase-2 inhibition and renal physiology American Journal of Cardiology 89 2002 10D-17D
72. Whelton A Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications American Journal of Medicine 106 1999 13S-24S
73. Lee A Cooper MC Craig JC et al. Effects of nonsteroidal anti-inflammatory drugs on post-operative renal function in normal adults Cochrane Database of Systematic Reviews 2: 2001 CD002765
74. Swan SK Rudy DW Lasseter KC et al. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial Annals of Internal Medicine 133 2000 1-9
75. Zhao S.Z. Reynolds M.W. Lejkowith J. et al. A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database Clinical Therapeutics 23 2001 1478-1491
76. Bennett W.M. DeBroe M.E. Analgesic nephropathy - a preventable renal disease New England Journal of Medicine 320 1989 1269-1271
77. Blohme I Johansson S Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy Kidney International 20 1981 671-675
78. Nielsen JD Holm-Nielsen A. Jespersen J. et al. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy - a prospective, randomized, double-blind, placebo-controlled study Scandinavian Journal of Urology and Nephrology 34 2000 194-198
79. Ferraris V.A. Ferraris S.P. Lough F.C. et al. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting Annals of Thoracic Surgery 45 1988 71-74
80. Bashein G Nessly ML Rice AL et al. Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery Archives of Internal Medicine 151 1991 89-93
81. Bing RJ Lomnicka M Why do cyclo-oxygenase-2 inhibitors cause cardiovascular events? Journal of the American College of Cardiology 39 2002 521-522
82. Catella-Lawson F Crofford LJ Cyclooxygenase inhibition and thrombogenicity American Journal of Medicine 110 2001 28S-32S supplement 3A
83. Bombardier C Laine L Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis VIGOR Study Group New England Journal of Medicine 343 2000 1520-1528
84. Johnson AG Nguyen TV Day RO Do nonsteroidal anti-inflammatory drugs affect blood pressure? Ameta-analysis Annals of Internal Medicine 121 1994 289-300
85. Komers R Anderson S Epstein M Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors American Journal of Kidney Disease 38 2001 1145-1157
86. Whelton A Fort JG Puma JA et al. Cyclooxygenase-2-specific inhibitors and cardiorenal function: arandomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients American Journal of Therapeutics 8 2001 85-95
87. Miwa K Kambara H Kawai C Effect of aspirin in large doses on attacks of variant angina American Heart Journal 105 1983 351-355
88. Mukerji V Alpert MA Flaker GC et al. Cardiac conduction abnormalities and atrial arrhythmias associated with salicylate toxicity Pharmacotherapy 6 1986 41-43
89. McGovern M.C. Glasgow J.F. Stewart M.C. Lesson of the week: Reye's syndrome and aspirin: lest we forget British Medical Journal 322 2001 1591-1592
90. Maxy R.J. Glassman S.D. The effect of nonsteroidal anti-inflammatory drugs on osteogenesis and spinal fusion Regional Anesthesia and Pain Medicine 26 2001 156-158
91. Raisz LG Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease American Journal of Medicine 110 2001 43S-45S supplement 3A
92. Lipsky P.E. Brooks P. Crofford L.J. et al.Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease Archives of Internal Medicine 160 2000 913-920
93. He J. Whelton P.K. Vu B. et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials JAMA 280 1998 1930-1935
94. Norman R.J. Reproductive consequences of COX-2 inhibition Lancet 358 2001 1287-1288
95. Cuzzolin L. Dal Cere M. Fanos V. NSAID-induced nephrotoxicity from the fetus to the child Drug Safety 24 2001 9-18
96. Smolinske SC Hall AH Vandenberg SA et al. Toxic effects of nonsteroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships Drug Safety 5 1990 252-274
97. Hall L.G. Oyen L.J. Murray M.J. Analgesic agents. Pharmacology and application in critical care Critical Care Clinics 17 2001 899-923